Albert Invent, an end-to-end R&D platform that accelerates chemical innovation in materials science through AI and machine learning, announced a growth funding round led by J.P. Morgan Private Capital’s Growth Equity Partners, with participation from Coatue and TCV. This round brings Albert Invent’s total funding to over $45 million.
The funding will be used to continue building the team globally and hiring in Germany, Japan, India, and the US. The company will also scale to meet customer demand for Albert Invent as a shift toward digitalization continues to drive growth globally.
Albert Invent is utilized by the world’s leading chemical, material science, and personal care companies including Chemours, Diversey, Henkel, Keystone Industries, Nouryon, and Solenis to unify R&D processes, accelerate innovation through AI, and transform how new products are brought to market.
Albert Invent was created to solve a massive problem in the chemical industry: siloed, disparate data. And Albert Invent creates a unified data model and centralizes workflows across entire organizations, pulling together all historical information on past experiments. The company also pioneered innovative methods for digitalizing and unifying research records at scale from paper notebooks to fragmented legacy software systems and isolated desktop files. This expertise enabled Albert to successfully structure and integrate hundreds of years of experimental data for the world’s leading chemical companies.
Last year, the company announced its $22 million Series A round and its latest innovation, Albert Breakthrough, which offers an intuitive interface where chemists and AI can collaborate seamlessly. By utilizing its deep understanding of chemistry down to the molecular level, Breakthrough assists scientists in generating experimental suggestions, predicting molecular properties, and optimizing formulations.
KEY QUOTES:
“Albert Invent is fundamentally transforming the science behind the physical world. By combining AI with a foundational model of chemistry, we’re empowering scientists to solve humanity’s greatest challenges – from sustainable materials and new battery technologies to chemical breakthroughs like self-reversible adhesives. We’re not just accelerating R&D; we’re enabling the next generation of scientific discoveries that will define our future.”
“We’ve seen tremendous demand from the top chemical and material science companies – we’re thrilled to have support from our investors and leadership of J.P. Morgan Growth Equity Partners to fuel our rapid growth and bolster our mission to empower scientists and accelerate innovation.”
– Nick Talken, CEO and co-founder of Albert Invent
“J.P. Morgan has deep roots and history in the Chemicals industry, dating back to 1823. We believe this technology is essential for the future of material development and how we build materials that power our lives. We’re excited to partner with Albert Invent to support their mission in bringing digital transformation to the chemical industry and advancing chemical science for chemists globally.”
– Luke Sikora, Partner at J.P. Morgan Growth Equity Partners
“Albert Invent has brought greater speed, lower costs, higher quality, and global regulatory compliance to all of our projects, from idea to commercialization. Thanks to Albert Breakthrough, projects that would traditionally take 3 months now take as little as 2 days.”
– Paul Snowwhite, CEO of Applied Molecules
